Effect of immunosuppressive drugs in immune‐mediated inflammatory disease during the coronavirus pandemic-Reference-Cited by-同舟云学术

Effect of immunosuppressive drugs in immune‐mediated inflammatory disease during the coronavirus pandemic

Published:2020-09-14 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Giuliani Federica¹^ORCID,Gualdi Giulio¹²^ORCID,Amerio Paolo¹²^ORCID

Affiliation:

1. Clinical Research Center—CAST, Center for Advanced Science and Technology “G. d'Annunzio” Foundation Chieti Italy

2. Dermatologic Clinic, Department of Medicine and Ageing Science “G. d'Annunzio” University Chieti Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14204

Reference42 articles.

1. Should biologics for psoriasis be interrupted in the era of COVID‐19?;Lebwohl M;Asian Pac J Cancer Prev,2020

2. BrennerEJ UR ColombelJF KappelmanMD.SECURE‐IBD database public data update. covidibd.org.2020.

3. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?

4. Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement;Damiani G;Clin Rheumatol,2020

5. Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special Issue “Clinical Consequences of COVID-19”: Taking a Look at Complexity;Journal of Clinical Medicine;2023-12-18

2. Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran;Dermatology Reports;2023-05-23

3. Dermatology Publications on COVID-19 during the First Pandemic Year: Creativity or Opportunism?;Life;2023-04-05

4. Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review;Vaccines;2022-02-15